Slovenian company part of innovative gene therapy
Ajdovščina, 1 June - The US Food and Drug Administration has approved the first gene therapy to treat babies with spinal muscular atrophy, an innovative therapy that also involves technology developed by the Slovenian company Bia Separations.
The rest of this news item is available to subscribers.
The news item consists of 1.260 characters (without spaces) or 235 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.